Senti Biosciences Holdings, Inc. (SNTI) Operating margin 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) operating margin by fiscal year — reported operating income divided by reported revenue.
-312631.8%FY2025 · since FY2021: -1765.4% → -312631.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -312631.8% | — |
| FY2023 | -4687.9% | -2798.6 pp |
| FY2022 | -1889.3% | -123.9 pp |
| FY2021 | -1765.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating cash flowSNTI Free cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →